Home > Boards > US Listed > Biotechs >

Eiger BioPharmaceuticals (EIGR)

Add EIGR Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 3/30/2022 9:41:33 AM - Followers: 33 - Board type: Free - Posts Today: 0

Celladon to Merge with Eiger

 Celladon Corporation (Nasdaq:CLDN) and Eiger BioPharmaceuticals, Inc., a privately-held biopharmaceutical company, today announced that they have entered into a definitive merger agreement under which the stockholders of Eiger would become the majority owners of Celladon, and the operations of Celladon and Eiger would be combined. The proposed merger remains subject to certain conditions, including the approval of Celladon stockholders.  If approved, upon closing of the transaction, Celladon will be renamed Eiger BioPharmaceuticals, Inc.
An investor syndicate has committed to invest $39.5 million in the combined company including new investors HBM Healthcare Investments, RA Capital Management, Sabby Management, Sphera Global Healthcare, Perceptive Advisors and Monashee Capital Partners together with existing long-time Eiger stockholders, ViVo Capital and InterWest Partners.  Six million dollars of the financing has already been funded, and the remaining $33.5 million is expected to close contemporaneously with the completion of the proposed merger.  The total cash balance of the combined company upon the closing of the proposed merger and the financing is expected to be greater than $60 million.
The proposed merger will create a clinical-stage company with a diversified development portfolio of product candidates addressing novel targets for four distinct orphan diseases: Hepatitis Delta Virus, bariatric surgery-induced hyperinsulinemic hypoglycemia, pulmonary arterial hypertension, and lymphedema.


Current Share Structure:

Outstanding shares as of October 31, 2015 was 23,916,021

Authorized shares as of October 31, 2015 was 200,000,000



About the Proposed Merger

Existing Eiger stockholders as well as investors in the contemporaneous financing will receive newly issued shares of Celladon common stock in connection with the proposed merger.  Celladon is expected to issue approximately 85.0 million new shares of its common stock to Eiger stockholders and participants in the financing.  On a pro forma basis for the combined company, current Celladon shareholders are expected to own approximately 22%, current Eiger shareholders approximately 45% and the new Eiger investor syndicate approximately 33%, each on a fully-diluted basis.

The transaction has been unanimously approved by the boards of directors of both companies, and a majority of Eiger stockholders have agreed to vote in favor of the transaction. The proposed merger is expected to close in the first half of 2016, subject to the approval of the stockholders of each company as well as regulatory approval and other customary conditions.  The merger agreement contains further details with respect to the proposed merger.

Celladon’s exclusive financial advisor in the transaction is Wedbush PacGrow Healthcare.  Jefferies LLC is acting as lead financial advisor to Eiger and Piper Jaffray is acting as financial advisor.  Pillsbury Winthrop Shaw Pittman LLP served as legal counsel to Celladon and Cooley LLP served as legal counsel to Eiger.


Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#1035   $50,000,000 share offering. This is adding approximately 1/6 make it happen 03/30/22 09:41:33 AM
#1034   lol TrendTrade2016 03/23/22 10:12:40 AM
#1033   Nice analysis TrendTrade2016 03/22/22 12:16:55 PM
#1032   lmao TrendTrade2016 03/21/22 11:59:44 AM
#1031   monster rare drug play TrendTrade2016 03/21/22 11:45:13 AM
#1030   very nice push coming....rare disease drugs are expensive!! TrendTrade2016 03/21/22 11:19:44 AM
#1029   Literally losing over $440,000,000 million a year with make it happen 03/17/22 11:16:40 AM
#1028   Volume is not sustainable imo and did a make it happen 03/17/22 10:33:09 AM
#1027   watch and learn loser TrendTrade2016 03/17/22 10:28:07 AM
#1026   Mid tripple digit negative profitability over 600% NEGATIVE. make it happen 03/17/22 09:43:56 AM
#1025   EIGR monster TrendTrade2016 03/17/22 09:37:54 AM
#1024   massive bio play taking off in pre! TrendTrade2016 03/17/22 09:03:45 AM
#1023   jhpratt@alphavestcapital.com is my email.Please email me insights into eigr. ae kusterer 02/08/21 08:50:08 PM
#1022   Dead though lol Penny chatter 11/23/20 08:57:00 AM
#1021   more NEWS https://ih.advfn.com/stock-market/NASDAQ/eiger-biopharmaceuticals-EIGR G2G 11/23/20 08:53:17 AM
#1020   Let’s go over $20... Oger 11/22/20 11:01:08 PM
#1019   They say the right things in the conference Penny chatter 11/22/20 10:41:10 PM
#1018   You think this rocks tomorrow penny chatter? Oger 11/22/20 10:37:21 PM
#1017   Think someone will be stated it. I looked Penny chatter 11/22/20 10:35:24 PM
#1016   Who’s the buyer? Oger 11/22/20 10:33:45 PM
#1015   Folks miss the covid implications here and they Penny chatter 11/22/20 06:24:54 PM
#1014   It will sink it the magnitude of this Oger 11/21/20 11:16:02 AM
#1013   I agree as it has 80% institutional ownership Penny chatter 11/21/20 09:15:58 AM
#1012   Over $20 on Monday...... Oger 11/20/20 10:11:30 PM
#1011   They didn't have to halt for this lol Penny chatter 11/20/20 07:45:47 PM
#1010   https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment G2G 11/20/20 07:16:33 PM
#1009   What kind of fda approval don't see interest? Penny chatter 11/20/20 07:12:41 PM
#1008   On it Penny chatter 11/20/20 06:10:53 PM
#1007   HALTED PENDING NEWS 11/20/2020 16:53:30 EIGR Eiger BioPharma NASDAQ G2G 11/20/20 05:00:20 PM
#1006   EIGR - Lambda is most paradoxical interferon : Fezziwig2008 08/22/20 01:08:50 PM
#1005   A mutual friend we have really likes it. Small MWM 08/18/20 09:10:26 PM
#1004   EIGR is expected to release interim data from Fezziwig2008 08/18/20 08:46:47 PM
#1003   https://seekingalpha.com/instablog/52316800-friar-tuck-esq/5480909-eiger-biophar MWM 08/18/20 03:59:28 PM
#1002   $EIGR what is Cooking? MWM 08/18/20 03:49:49 PM
#1001   EIGR is cooking... MWM 08/10/20 10:02:41 AM
#1000   EIGR ”Although no synthetic IFN-lambda is yet FDA-approved, Fezziwig2008 08/03/20 10:54:48 AM
#999   On EIGR (Lambda is IFN III) “Treatment with Fezziwig2008 07/29/20 06:14:31 AM
#998   EIGR “IFN-Lambda4 showed a strong therapeutic effect in Fezziwig2008 07/26/20 04:40:24 PM
#997   EIGR ”Although no synthetic IFN-lambda is yet FDA-approved, Fezziwig2008 07/22/20 11:22:41 PM
#996   New EIGR LAMBDA Trial in Canada -Why would Fezziwig2008 07/19/20 11:00:31 AM
#995   EIGR Antiviral Anti ARDS Mechanism of Action -Derek Fezziwig2008 07/16/20 11:41:19 AM
#994   EIGR for COVID ARDS -“We conclude that IFN Fezziwig2008 07/16/20 10:30:05 AM
#993   EIGR Science on IHUB not Twitter. Fezziwig2008 07/15/20 10:26:06 AM
#992   EIGR Positive Data from Stanford Soon “IFN-? has Fezziwig2008 07/15/20 09:49:47 AM
#991   EIGR on watch... MWM 06/09/20 09:33:28 AM
#990   8.4M common shares outstanding xr_biotech_consult 07/31/17 03:35:57 PM
#989   $49M cash and investments as of March 31, 2017 xr_biotech_consult 07/31/17 03:35:17 PM
#988   Oppenheimer Reaffirms $34 Target On Eiger Biopharmaceuticals (EIGR), xr_biotech_consult 07/31/17 03:33:49 PM
#987   Out at $9.60. But way stronger than had chmcnfunds 07/14/17 12:51:51 PM
#986   BTIG Starts Eiger BioPharma (EIGR) at Buy chmcnfunds 07/14/17 08:25:23 AM
Consent Preferences